During the past decade, Saint Mary of Nazareth Hospital Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Mary of Nazareth Hospital Center" #1 collaborator was "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Saint Mary of Nazareth Hospital Center" are "Dopamine Beta Hydroxylase Deficiency" (2 trials), "Multiple System Atrophy" (1 trials), "Neurogenic Orthostatic Hypotension" (1 trials), "Non-Diabetic Autonomic Neuropathy" (1 trials) and "Non-diabetic Neuropathy" (1 trials). Many other conditions were trialed in "Saint Mary of Nazareth Hospital Center" in a lesser frequency.

Most popular intervention types in "Saint Mary of Nazareth Hospital Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Droxidopa" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Saint Mary of Nazareth Hospital Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Saint Mary of Nazareth Hospital Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Saint Mary of Nazareth Hospital Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Saint Mary of Nazareth Hospital Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".